ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced its strategic collaboration with ImageBiopsy Lab, a pioneering company specializing in artificial intelligence solutions for musculoskeletal (MSK) imaging. This collaboration will integrate ImageBiopsy Lab’s innovative IB Lab solutions into TeraRecon’s Eureka Clinical AI platform.
The integration of ImageBiopsy Lab’s powerful AI-driven solutions with the Eureka Clinical AI platform will automate measurements in MSKdiagnostics on radiographs, providing radiologists and orthopedists with fast, quantitative, and standardized knee, hip, leg, hand, and spine reports. By combining TeraRecon’s industry-leading expertise in advanced imaging with ImageBiopsy Lab’s AI algorithms, medical professionals will benefit from cutting-edge technology that helps clinicians identify and extract key disease parameters, which are critical for the prevention and treatment of various MSK-related conditions.
“Our collaboration with ImageBiopsy Lab is a significant step in advancing radiology practice,” said Dan McSweeney, President of TeraRecon. “The addition of IB Lab solutions to the TeraRecon Eureka Clinical AI platform aims to provide our customers with AI-powered tools that assist in standardizing this highly subjective diagnostic workflow for the interpretation of musculoskeletal images.”
The IB Lab solutions offered by ImageBiopsy Lab employ AI algorithms that analyze radiological images, enabling automated detection of fractures, degenerative conditions, and other MSK anomalies. The integration with TeraRecon’s Eureka Clinical AI platform will facilitate seamless workflow integration and easy access to these advanced AI capabilities.
“We are excited to collaborate with TeraRecon to bring our cutting-edge AI solutions to a broader audience,” said Dr. Richard Ljuhar, CEO of ImageBiopsy Lab. “By combining our expertise in musculoskeletal AI with TeraRecon, we hope to empower radiologists and orthopedic specialists to achieve new levels of diagnostic precision and patient care.”
SOURCE: PRNewswire
